Whitepapers

State of MSK Report 2026

The 2026 State of MSK Care report features a dual‑perspective survey of 1,000 patients and 295 providers that reveals four misalignments driving overspend and fragmented MSK care.

Move Beyond Pain: The State of MSK Care 2025

Backed by 10 years of Hinge Health data, our State of MSK Care 2025 report dives into how digital solutions make physical therapy more convenient, habit-forming, accessible, and effective at delivering results than traditional PT.

What women want you to know about their pain

Survey results highlight the impact of musculoskeletal (MSK) pain on the women in your workforce—and why they need your help to better manage it.

The State of MSK Care 2024

A national consumer survey of 10,000 Americans in musculoskeletal pain.

Fall prevention: Rising to the challenge

Fall are the #1 source of injury in older adults, costing Medicare over $29 billion a year.

The Key to More Inclusive Women’s Health Benefits? Awareness and Access

While many companies claim to offer holistic support for women's health through their benefits plans, employers often overlook a critical coverage are: pelvic floor disorders.

The State of MSK Care 2023: Helping People Move Beyond Pain

Hinge Health's The State of MSK Care 2023 report explores the staggering human and economic costs of musculoskeletal (MSK) pain for individuals and employers.

Taking an Innovative Path to Addressing the Burden of Musculoskeletal Disorders

MSK costs are highly avoidable: The key is thinking bigger.

HPIR

Breaking the costly cycle of chronic pain: How health plans can address musculoskeletal conditions with digital health programs

The State of MSK Report 2022

Hinge Health analyzes National Health Interview Survey data to identify gaps and challenges related to the management of MSK conditions

Disparities in MSK Care

Learn 5 social determinants of health and 4 ways employers can narrow the health equity gap.

Treating the Whole Person

Discover how the whole-body approach to MSK results in better outcomes at lower spend.